Contineum Therapeutics, Inc. Class A Common StockCTNMNASDAQ
Loading
Year-over-year SG&A expense growth
| Period | Value |
|---|---|
| Q4 2025 | 10.66% |
| Q3 2025 | 2.63% |
| Q2 2025 | -12.71% |
| Q1 2025 | 9.08% |
| Q4 2024 | 24.21% |
| Q3 2024 | 6.67% |
| Q2 2024 | 41.40% |
| Q1 2024 | 29.33% |
| Q4 2023 | 5.99% |
| Q3 2023 | -2.06% |
| Q2 2023 | 13.69% |
| Q1 2023 | -0.28% |
| Q4 2022 | 0.00% |